↓ Skip to main content

Ponatinib, Lestaurtinib, and mTOR/PI3K Inhibitors Are Promising Repurposing Candidates against Entamoeba histolytica

Overview of attention for article published in Antimicrobial Agents and Chemotherapy, December 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent
2 patents

Readers on

mendeley
24 Mendeley